Deborah Morosini, EVP, Chief of Clinical Affairs at Prelude Therapeutics Inc (PRLD), bought 444 shares at $19.00 ($8K) on 2020-09-29, disclosed to the SEC on 2020-09-29.
Open-market purchase of $8k PRLD by EVP, Chief of Clinical Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PRLD | SELL | 2021-04-30 | $260K | — | Filing → |
| PRLD | SELL | 2021-04-15 | $4K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $40K | — | Filing → |